Table 2. NR2B antagonists and their affinity for the receptor: in vitro and functional binding.
NR2B antagonists | Pharmaceutical Company | NR2B | NR2A | NR2C | Assays | References |
Merck 22 | Merck & Co Inc | Ki = 0.88 nM | ND | ND | In vitro Binding | [49] |
Radiprodil | Gedeon Richter | IC50 = 3–10 nM | IC50>10 µM | ND | In vitro Binding | [69] |
UCB | ||||||
Co-101,244 | Parke-Davis | IC50 = 0.026 µM | IC50 = 230 µM | IC50 = 590 µM | TEVC recording | [33], [74] |
Pfizer | IC50 = 0.043 µM | IC50>100 µM | IC50>100 µM | |||
IC50 = 4 nM | In vitro binding | [75] |
ND: no data available.